Skip to main content

Table 1 Annualised economic cost of establishing and implementing SPARS

From: Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda

  1. *Costs covered within existing duties, salaries or by government ordinary expenses
  2. **Although funded by the donor, PIP development cost was not included in the calculations as the SPARS does not depend on PIP
Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us